GGrantIndex
← Leaderboards

Gerald V. Quinnan

Henry M. Jackson Fdn For The Adv Mil/Med

$7,049,155
Attributed
$7,049,155
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200512
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$11,643,353 · 5

By mechanism

P01$4,594,198 · 2
R01$4,132,487 · 2
U01$2,916,668 · 1

Top collaborators

No co-investigators on record.

Most similar at Henry M. Jackson Fdn For The Adv Mil/Med

Same institution · by research overlap

Others in their field

Top investigators on “Neutralizing Antibody

Research focus

Neutralizing AntibodyAids VaccinesHiv Envelope Protein Gp120Vaccine DevelopmentHuman Immunodeficiency Virus 1SpecificityMediatingOryctolagus CuniculusActive ImmunizationAntigensImmunizationEpitopesAntibodiesResponseCross ReactivityAdjuvantDesignHiv-1Laboratory MouseClinical ResearchHuman TissueCross ImmunityHiv Envelope ProteinVenezuelan Equine Encephalitis Virus

Grant awards (20)

High Potency HIV-1 Broadly Cross-Reactive Neutralization$580,675
U01 · FY2012 · AI · contact PI
High Potency HIV-1 Broadly Cross-Reactive Neutralization$581,202
U01 · FY2011 · AI · contact PI
High Potency HIV-1 Broadly Cross-Reactive Neutralization$587,053
U01 · FY2010 · AI · contact PI
High Potency HIV-1 Broadly Cross-Reactive Neutralization$576,160
U01 · FY2009 · AI · contact PI
HIGHLY EFFECTIVE NEUTRALIZING ANTIBODIES AGAINST SHIV$536,001
R01 · FY2009 · AI · contact PI
High Potency HIV-1 Broadly Cross-Reactive Neutralization$591,578
U01 · FY2008 · AI · contact PI
HIGHLY EFFECTIVE NEUTRALIZING ANTIBODIES AGAINST SHIV$577,416
R01 · FY2008 · AI · contact PI
HIGHLY EFFECTIVE NEUTRALIZING ANTIBODIES AGAINST SHIV$586,880
R01 · FY2007 · AI · contact PI
HIGHLY EFFECTIVE NEUTRALIZING ANTIBODIES AGAINST SHIV$592,435
R01 · FY2006 · AI · contact PI
HIGHLY EFFECTIVE NEUTRALIZING ANTIBODIES AGAINST SHIV$543,005
R01 · FY2005 · AI
NEUTRALIZATION RESISTANCE OF HIV-1$259,350
R01 · FY2005 · AI
NEUTRALIZATION RESISTANCE OF HIV-1$259,350
R01 · FY2004 · AI
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1$1,570,350
P01 · FY2003 · AI
NEUTRALIZATION RESISTANCE OF HIV-1$259,350
R01 · FY2003 · AI
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1$1,452,497
P01 · FY2002 · AI
NEUTRALIZATION RESISTANCE OF HIV-1$259,350
R01 · FY2002 · AI
Broad Neutralizing Response to HIVenv/VEE Replicons$0
P01 · FY2002 · AI
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1$1,571,351
P01 · FY2001 · AI
NEUTRALIZATION RESISTANCE OF HIV-1$259,350
R01 · FY2001 · AI
Broad Neutralizing Response to HIVenv/VEE Replicons$0
P01 · FY2001 · AI